This multifunctional and biocompatible IR783‐stabilized nanosystem offers a promising strategy for HDAC inhibition‐enhanced oxidation therapy and holds the potential for clinical translation and cancer treatment in the future. The gene discussed is HDAC9; the disease is cancer.